Home
>
US Stocks
>
Pulmonx Corp
Pulmonx Corp
LUNG

Pulmonx Corp (LUNG)

$39.562.43%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
39.69
Today Low/High
39.14 / 39.91
52 Week Low/High
$35.81 / $69.48
Market Cap
$1.37B

Company Details

Pulmonx Corporation is a commercial-stage medical technology company. The Company is focused on providing planning tools and treatments for obstructive lung disease. Its solutions include Zephyr Valve, Chartis Pulmonary Assessment System and StratX Lung Analysis Platform. The Company's solutions offer minimally invasive treatment option for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). Its solution provides bronchoscopic lung volume reduction without surgery. The Zephyr Valves are indicated for bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valves are placed in the airways to occlude the diseased parts of the lung, allowing trapped air to escape.
Organisation
Pulmonx Corp
Headquaters
Redwood City, California, US
Employees
220
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Pulmonx Corp (LUNG) share price today?

Can Indians buy Pulmonx Corp (LUNG) shares?

How can I buy Pulmonx Corp (LUNG) shares from India?

Can Fractional shares of Pulmonx Corp (LUNG) be purchased?

What are the documents required to start investing in Pulmonx Corp (LUNG) stocks?

We are a SEBI registered investement advisor